[HTML][HTML] Cellular senescence in cardiovascular diseases: a systematic review

C Hu, X Zhang, T Teng, ZG Ma, QZ Tang - Aging and disease, 2022 - ncbi.nlm.nih.gov
… cells) in age-related cardiovascular diseases. Then, we highlight the targets (SIRT1 and
mTOR) that regulating cellular senescence in cardiovascular disorders. Furthermore, we review …

The role of cellular senescence in cardiac disease: basic biology and clinical relevance

M Mehdizadeh, M Aguilar, E Thorin… - Nature Reviews …, 2022 - nature.com
… prevent and/or treat chronic cardiac disease and the safety of … role of cellular senescence
in cardiac disease potentially has … information linking cellular senescence to cardiac disease, …

Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies

S Xu, I Ilyas, PJ Little, H Li, D Kamato, X Zheng… - Pharmacological …, 2021 - ASPET
The endothelium, a cellular monolayer lining the blood vessel wall, plays a critical role in
maintaining multiorgan health and homeostasis. Endothelial functions in health include …

[HTML][HTML] Oxidative stress and antioxidant treatments in cardiovascular diseases

W Wang, PM Kang - Antioxidants, 2020 - mdpi.com
… as a second messenger in cellular signaling. Through targeting … Cardiovascular diseases
are the leading cause of morbidity … the progression of various cardiovascular diseases, such as …

NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseases

Y Wang, X Liu, H Shi, Y Yu, Y Yu, M Li… - Clinical and …, 2020 - Wiley Online Library
… Inflammation is an important process involved in several cardiovascular diseases (CVDs),
and nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is a vital …

Therapeutic potential of polyphenols in cardiovascular diseases: Regulation of mTOR signaling pathway

A Sanches-Silva, L Testai, SF Nabavi, M Battino… - Pharmacological …, 2020 - Elsevier
… In fact, without the identification of a specific and direct cellular target, it is very difficult to
evaluate their clinical relevance. An additional key issue regards “who does the job”, the …

Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases

C Schiano, G Benincasa, M Franzese… - Pharmacology & …, 2020 - Elsevier
… The complex pathobiology underlying cardiovascular diseases (CVDs) has yet to be … ,
diagnostic and prognostic biomarkers as well as drug targets in CVDs. To date, most of studies …

[HTML][HTML] Oxidative stress in cardiovascular diseases

E Dubois-Deruy, V Peugnet, A Turkieh, F Pinet - Antioxidants, 2020 - mdpi.com
Cardiovascular diseases comprise several disorders such as coronary artery diseases,
stroke, hypertension, heart failure, congenital heart diseases, and vascular diseases. The …

[HTML][HTML] Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases

L Recinella, G Orlando, C Ferrante… - Frontiers in …, 2020 - frontiersin.org
coronary artery disease. In addition, a study conducted in 40 patients suffering from T2DM
with cardiovascular disease … with the prognosis of cardiovascular complications. In particular, …

[HTML][HTML] Extracellular vesicles in cardiovascular diseases

S Fu, Y Zhang, Y Li, L Luo, Y Zhao, Y Yao - Cell death discovery, 2020 - nature.com
… Endotheliocytes and platelets have been shown to be the major sources of EVs in patients
with stable coronary artery disease (CAD). Atherosclerotic conditions promote the packaging …